Navamedic ASA acquires Impolin AB and bolsters its product portfolio Published: 05.05.2022 Navamedic ASA launches SmectaGO[®] – an innovative on-the-go product for treatment of diarrhea Published: 16.02.2022 Treating the side-effects of the pandemic Published: 24.06.2021 Navamedic ASA (“Navamedic”, OSE: NAVA) announces it has won the tender for certain antibiotics to the Norwegian hospital market Published: 17.06.2021 Navamedic ASA: Icepharma new distributor of antibiotics to the Icelandic market Published: 07.05.2021 Navamedic ASA: Enters long term distribution agreement for PrecisionBiotics Zenflore® in the Nordics with Novozymes. Published: 08.04.2021 FirstPrevious1234NextLast
Navamedic ASA launches SmectaGO[®] – an innovative on-the-go product for treatment of diarrhea Published: 16.02.2022
Navamedic ASA (“Navamedic”, OSE: NAVA) announces it has won the tender for certain antibiotics to the Norwegian hospital market Published: 17.06.2021
Navamedic ASA: Icepharma new distributor of antibiotics to the Icelandic market Published: 07.05.2021
Navamedic ASA: Enters long term distribution agreement for PrecisionBiotics Zenflore® in the Nordics with Novozymes. Published: 08.04.2021